AstraZeneca Pharmaceuticals LP
67 drugs in NADAC|2 Generic,65 Brand
View Recalls (4)AstraZeneca Pharmaceuticals LP lists 67 NDCs in the CMS NADAC file (2 generic, 65 brand), at an average NADAC of $38.50 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
67
2G / 65B
Avg Price / Unit
$38.4998
$3.71 – $681.26
Avg 7d Change
-0.06%
Across 33 drugs with changes
7d Activity
of 67 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
quetiapine market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Corticosteroid therapeutic class
Review the broader class where AstraZeneca Pharmaceuticals LP has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does AstraZeneca Pharmaceuticals LP make?
AstraZeneca Pharmaceuticals LP lists 67 NDCs in the CMS NADAC file — 2 generic and 65 brand products.
What is the average price of AstraZeneca Pharmaceuticals LP drugs?
The average NADAC across AstraZeneca Pharmaceuticals LP's portfolio is $38.4998 per unit, ranging from $3.7108 to $681.2626.
What types of drugs does AstraZeneca Pharmaceuticals LP make?
AstraZeneca Pharmaceuticals LP makes drugs across 14 FDA pharmacologic classes. The most common by NDC count are Corticosteroid (12), Atypical Antipsychotic (11), beta2-Adrenergic Agonist (10), Sodium-Glucose Cotransporter 2 Inhibitor (10), Proton Pump Inhibitor (9).
Has AstraZeneca Pharmaceuticals LP had any drug recalls?
4 FDA recalls are matched to AstraZeneca Pharmaceuticals LP in the openFDA feed, most recently on Feb 23, 2018.
How has AstraZeneca Pharmaceuticals LP's pricing changed recently?
Over the past 7 days, 19 AstraZeneca Pharmaceuticals LP products rose and 14 fell, with a portfolio-wide average change of -0.1%.
FDA Recalls (4)
Recalls matched by company name. Verify current status with FDA.
Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850 by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.
Defective Delivery System: Some units have actuation counters set to a number other than 60.
NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.
Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.
MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30
Presence of Precipitate; potential for incomplete constitution upon addition of diluent.